Jonathan Rubin
Chief Tech/Sci/R&D Officer at SUPERNUS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 30/04/2024
Jonathan Rubin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 | - |
| Corporate Officer/Principal | 01/02/2020 | 01/01/2021 |
Career history of Jonathan Rubin
Former positions of Jonathan Rubin
| Companies | Position | Start | End |
|---|---|---|---|
Atentiv LLC
 Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/05/2018 | 01/02/2020 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Chief Tech/Sci/R&D Officer | 26/08/2013 | 01/09/2017 |
| Shire Development LLC | Chief Tech/Sci/R&D Officer | - | - |
Training of Jonathan Rubin
| Yale University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
| The University of Connecticut School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
| Israel | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
| Shire Development LLC | |
Atentiv LLC
Atentiv LLC Packaged SoftwareTechnology Services Atentiv LLC develops educational and digital learning tools. The company is based in Waltham, MA. | Technology Services |
- Stock Market
- Insiders
- Jonathan Rubin
- Experience
